Nondepolarizing neuromuscular blocking drugs in the intensive care unit: A clinical review

Southern Medical Journal

Volumn 90, Issue 8, 1997, Pages 769-774

  Reeves, Scott T ^a,b   Turcasso, Nannette M ^a,b  

^a Medical University of South Carolina ^*

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ATRACURIUM; ATRACURIUM BESILATE; CARBAMAZEPINE; CLINDAMYCIN; CORTICOSTEROID; DOXACURIUM; LITHIUM CARBONATE; MAGNESIUM SALT; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PHENYTOIN; POLYMYXIN B; ROCURONIUM; TETRACYCLINE; VANCOMYCIN; VECURONIUM;

ARTICLE; CARDIOVASCULAR DISEASE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MYOPATHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE;

ANDROSTANOLS; ATRACURIUM; DRUG INTERACTIONS; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; ISOQUINOLINES; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PANCURONIUM; VECURONIUM BROMIDE;

EID: 0030820591     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199708000-00001     Document Type: Article

References (47)

1. Silverman DG: Neuromuscular Block in Perioperative and Intensive Care. Philadelphia, JB Lippincott, 1994
2. Stoelting RK: Neuromuscular blocking drugs. Pharmacology & Physiology in Anesthetic Practice. Stoelting RK (ed). Philadelphia, JB Lippincott, 1991, pp 172-225
3. Hunter JM: New neuromuscular blocking drugs. N Engl J Med 1995; 332:1691-1699
4. Barash PG, Cullen BF, Stoelting RK: Muscle relaxants. Handbook of Clinical Anesthesia. Barash PG, Cullen BF, Stoelting RK (eds). Philadelphia, JB Lippincott, 1991, pp 162-180
5. Klessig HT, Geiger HJ, Murray MJ, et al: A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit Care Med 1992; 20:1341-1345
6. Shapiro BA, Warren J, Egol AB, et al: Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Crit Care Med 1995; 23:1601-1605
7. Bevan DR, Donati F: Muscle relaxants. Clinical Anesthesia. Barash PG, Cullen BF, Stoelting RK (eds). Philadelphia, JB Lippincott, 1992, pp 481-508
8. Taylor P: Agents acting at the neuromuscular junction and autonomic ganglia. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE, Molinoff PB, et al (eds). New York, McGraw-Hill, 1996, pp 177-197
9. McEvoy GK, Litvak K, Welsh OH: American Hospital Formulary Service Drug Information. Bethesda, American Society of Health-System Pharmacists Inc, 1996, pp 928-965
10. Watkins J: Adverse reaction to neuromuscular blockers: frequency, investigation, and epidemiology. Acta Anaesthesiol Scand 1994; 102:6-10
11. Kopman AF: Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? Anesthesiology 1989; 70:915-920
12. Bevan DR: Newer neuromuscular blocking agents. Pharmacol Toxicol 1994; 74:3-9
13. Rathmell JP, Brooker RF, Prielipp RC, et al: Hemodynamics and pharmacodynamic comparison of doxicurium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost? Anesth Analg 1993; 76:513-519
14. Welch R, Brown A, Dahl R: In vitro degradation of cisatracurium in Sorensen buffer, rat, and human plasma. Clin Pharmacol Ther 1995; 58:132-134
15. Shi WZ, Fahey MR, Fisher DM, et al: Modification of central nervous system effects of laudanosine by inhalational anesthetics. Br J Anaesth 1989; 63:598-600
16. Chapple DJ, Miller AA, Ward JB, et al: Cardiovascular and neurological effects of laudanosine. Br J Anaesth 1987; 59:218-257
17. Fahey MR, Canfell PC, Taboada T, et al: Cerebrospinal fluid concentrations of laudanosine after administration of atracurium. Br J Anaesth 1990; 64:105-106
18. Gwinnutt CL, Eddleston JM, Edwards D, et al: Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth 1990; 65:829-832
19. Agoston S, Vermeer GA, Kersten UW, et al: The fate of pancuronium during high dose fentanyl anesthesia for coronary artery bypass grafting. Anesthesiology 1995; 62:708-713
20. Westra P, Vermeer GA, de Lange AR: Hepatic and renal disposition of pancuronium and gallamine in patients with extra hepatic cholestasis. Br J Anaesth 1981; 53:331-338
21. Segredo V, Caldwell JE, Mathay MA, et al: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327:524-528
22. Caldwell JE, Szenohradszky J, Segredo V, et al: The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetyl-vecuronium (ORG7268) and its parent compound, vecuronium, in human volunteers. J Pharmacol Exp Ther 1994; 270:1216-1222
23. Wierda JMKH, Kleef UW, Lambalk LM,et al: The pharmacodynamics and pharmacokinetics of Org9426, a new nondepolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 1991; 38:430-435
24. Gooch JL: Prolonged paralysis after neuromuscular blockade. Clin Toxicol 1995; 33:419-426
25. Watling SM, Dasta JF: Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literature. Crit Care Med 1994; 22:884-893
26. Gooch JL, Suchyta MR, Balbierz JM, et al: Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 1991; 19:1125-1131
27. Lacomis D, Giuliani MJ, Cott AV, et al: Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 1996; 40:645-654
28. Leatherman JW, Fluegel WL, David WS, et al: Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1686-1690
29. Rich MM, Teener JW, Raps EC, et al: Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996; 46:731-736
30. Singh YN, Marshall IG, Harvey AL: Pre-and post-junctional blocking effects of aminoglycoside, polymixin, tetracycline and lincosamide antibiotics. Br J Anaesth 1982; 54:1295-1305
31. Singh YN, Marshall IG, Harvey AL: Some effects of the aminoglycoside antibiotic amikacin on neuromuscular and autonomic transmission. Br J Anaesth 1978; 50:109-117
32. Sokoll MD, Gergis SD: Antibiotics and neuromuscular function. Anesthesiology 1981; 55:148-159
33. Wright JM, Collier B: Characterization of the neuromuscular block produced by clindamycin and lincomycin. Can J Physiol Pharmacol 1976; 54:937-944
34. Abel M, Book WJ, Eisenkraft JB: Adverse effects of nondepolarizing neuromuscular blocking agents: incidence, prevention, and management. Drug Saf 1994; 10:420-438
35. Borden J, Clarke MT, Katz H: The use of pancuronium bromide in patients receiving lithium carbonate. Can Anaesth Soc J 1974; 21:79-82
36. Vizi ES, Ronai IP, Knoll J: The effect of lithium on acetylcholine release and synthesis. Neuropharmacology 1972; 11:521-530
37. Fuchs-Buder T, Tassonyi E: Magnesium sulphate enhances residual neuromuscular block induced by vecuronium. Br J Anaesth 1996; 76:565-566
38. Faulds D, Clissold SP: Doxacurium. a review of its pharmacology and clinical potential in anaesthesia. Drugs 1991; 42:673-689
39. Beemer GH, Bjorksten AR, Crankshaw DP: Pharmacokinetics of atracurium during continuous infusion. Br J Anaesth 1990; 65:668-674
40. Gordon KL, Reilly CS: Recovery of neuromuscular function after infusion or intermittent bolus doses of atracurium or vecuronium. Br J Anaesth 1989; 62:269-273
41. Gramstad L, Lilleaasen P: Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration. Br J Anaesth 1985; 57:1052-1059
42. Darrah WC, Johnston JR, Mirakhur RK: Vecuronium infusions for prolonged muscle relaxation in the intensive care unit. Crit Care Med 1989; 17:1297-1300
43. Buck ML, Reed MD: Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients. Clin Pharm 1991; 10:32-48
44. Murray MJ, Coursin DB, Scuderi PE, et al: Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Crit Care Med 1995; 23:450-458
45. Prielipp RC, Coursin DB, Scuderi PE, et al: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81:3-12
46. Khuenl-Brady KS, Sparr H, Pühringer F, et al: Rocuronium bromide in the ICU: dose finding and pharmacokinetics. Eur J Anaesthiol 1995; 12(suppl 11):79-80
47. Tobias JD: Continuous infusion of rocuronium in a paediatric intensive care unit. Can J Anaesth 1996; 43:353-357